Clinical Drug Experience Knowledgebase

Dwarfism, Pituitary

Astrocytoma (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Cachexia (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 2)

Chondrosarcoma (Phase 2)

Colonic Neoplasms (Phase 1)

Colorectal Neoplasms (Phase 3)

Dwarfism, Pituitary (Phase 3)

Endocrine System Diseases (Phase 3)

Endometrial Neoplasms (Phase 3)

Gastrointestinal Stromal Tumors (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Hypertrophy (Phase 3)

Kidney Neoplasms (Phase 3)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Leishmaniasis, Visceral (Phase 2)

Leukemia (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Multiple Myeloma (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 3)

Oligodendroglioma (Phase 2)

Ovarian Neoplasms (Phase 2)

Plasmacytoma (Phase 2)

Prostatic Hyperplasia (Phase 3)

Prostatic Neoplasms (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Alveolar Soft Part (Phase 2)

Waldenstrom Macroglobulinemia (Phase 2)

Wasting Syndrome (Phase 2)